A Randomized, Double-Blind, 2-Period Crossover Study to Evaluate the Effect of Single Dose JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Subjects
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Mibenratide (Primary) ; Metoprolol tartrate
- Indications Arrhythmias; Heart failure; Hypertension; Ischaemic heart disorders; Migraine
- Focus Pharmacodynamics
- 31 Oct 2016 Planned End Date changed from 1 Oct 2013 to 1 May 2014.
- 31 Oct 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 29 Jul 2013 New trial record